Literature DB >> 28715597

The proposal of a clinical protocol to assess central and peripheral fatigue in myotonic dystrophy type 1.

S Baldanzi1, G Ricci, M Bottari, L Chico, C Simoncini, G Siciliano.   

Abstract

DM1 is an autosomal-dominant disorder characterized by muscle weakness, myotonia, and multisystemic involvement. According to current literature fatigue and daytime sleepiness are among the main symptoms of DM1. Oxidative stress has been proposed to be one of the pathogenic factors of fatigue consequent to DM1. In this study, we investigated the dimensions of experienced fatigue and  physiological fatigue in a sample of 26 DM1 patients (17 males, 9 females, mean age 41.6 years, SD±12.7); experienced fatigue has been studied through Fatigue Severity Scale (FSS), and physiological fatigue was measured through an intermittent incremental exercise of the forearm muscles using a myometer; oxidative stress balance markers trend during aerobic exercise test have been collected. The occurrence of central fatigue in the sample means that central activation worsens during the motor contraction; interestingly FSS score was significantly correlated to MVC (before and after the effort, r-before=-0.583, p<0.01, r-after= -0.534, p<0.05), and to motor disability measured by MRC (r=-0.496, p<0.05); moreover we found a strong tendency towards significance in the association to lactate baseline (r=0.378, p=0.057).Results are discussed to define whether or not, based on clinical and laboratory grounds, such exercise training protocol may be suitable for proper management of DM1 patients; proper assessment of fatigue should be included in algorithms for data collection in DM1 patient registries.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28715597     DOI: 10.12871/000398292017125

Source DB:  PubMed          Journal:  Arch Ital Biol        ISSN: 0003-9829            Impact factor:   1.000


  5 in total

1.  Assessment of muscular strength and functional capacity in the juvenile and adult myotonic dystrophy type 1 population: a 3-year follow-up study.

Authors:  Marie-Pier Roussel; Marie-Michèle Fiset; Laurie Gauthier; Claudia Lavoie; Émilie McNicoll; Laurie Pouliot; Cynthia Gagnon; Elise Duchesne
Journal:  J Neurol       Date:  2021-04-27       Impact factor: 4.849

Review 2.  Myotonic Dystrophies: Targeting Therapies for Multisystem Disease.

Authors:  Samantha LoRusso; Benjamin Weiner; W David Arnold
Journal:  Neurotherapeutics       Date:  2018-10       Impact factor: 7.620

Review 3.  Dissecting the fatigue experience: A scoping review of fatigue definitions, dimensions, and measures in non-oncologic medical conditions.

Authors:  Ruel Billones; Josephine K Liwang; Kierra Butler; Letitia Graves; Leorey N Saligan
Journal:  Brain Behav Immun Health       Date:  2021-05-21

4.  White matter integrity changes and neurocognitive functioning in adult-late onset DM1: a follow-up DTI study.

Authors:  Garazi Labayru; Borja Camino; Antonio Jimenez-Marin; Joana Garmendia; Jorge Villanua; Miren Zulaica; Jesus M Cortes; Adolfo López de Munain; Andone Sistiaga
Journal:  Sci Rep       Date:  2022-03-07       Impact factor: 4.379

5.  Fatigue in myotonic dystrophy type 1: a seven-year prospective study.

Authors:  Stojan Peric; Bogdan Bjelica; Ivo Bozovic; Jovan Pesovic; Teodora Paunic; Marija Banovic; Milos Brkusanin; Ksenija Aleksic; Ivana Basta; Dusanka Savic Pavicevic; Vidosava Rakocevic Stojanovic
Journal:  Acta Myol       Date:  2019-12-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.